What's going on in today's session: S&P500 movers
By Mill Chart
Last update: Apr 30, 2024
Top movers analysis one hour before the close of the markets of S&P500 on 2024-04-30: top gainers and losers in today's session.
Top gainers
| Ticker | Change | Comment |
|---|---|---|
| LDOS | 5.86% | LEIDOS HOLDINGS INC's (NYSE:LDOS) shares rose 5.86% to $139.33. LEIDOS HOLDINGS INC released earnings Yesterday. In the last 6 months the share price increased with 26.63%. |
| LLY | 5.77% | ELI LILLY & CO's (NYSE:LLY) shares rose 5.77% to $779.71 during Tuesday's session. The company's earnings where released Yesterday. Shareholders saw the stock price going 29.83% higher is the past 6 months. |
| TT | 5.55% | TRANE TECHNOLOGIES PLC's (NYSE:TT) stock price increased by 5.55% to $317.56. The company's earnings where released Yesterday. A press release (Trane Technologies Reports Strong First Quarter Results and Raises 2024 Revenue and EPS Guidance) was released yesterday. |
| GLW | 4.74% | CORNING INC's (NYSE:GLW) shares rose 4.74% to $33.29. CORNING INC released earnings Yesterday. A press release (Corning Reports First-Quarter 2024 Financial Results) was released earlier today. |
| MMM | 4.27% | 3M CO (NYSE:MMM) experienced a significant 4.27% increase, reaching $96.09 during Tuesday's session. 3M CO released earnings Yesterday. |
| ZBRA | 4.05% | ZEBRA TECHNOLOGIES CORP-CL A's (NASDAQ:ZBRA) shares rose 4.05% to $312.17 during Tuesday's session. ZEBRA TECHNOLOGIES CORP-CL A released earnings Yesterday. A press release (Zebra Technologies Announces First-Quarter 2024 Results) was released yesterday. |
| NXPI | 3.37% | NXP SEMICONDUCTORS NV (NASDAQ:NXPI) witnessed a notable 3.37% uptick in its shares, reaching $255.47 during Tuesday's session. Shareholders saw the stock price going 36.12% higher is the past 6 months. |
| ECL | 2.63% | Exciting news for ECOLAB INC (NYSE:ECL) as its stock price surged 2.63% to $227.5 during Tuesday's session. ECOLAB INC released earnings Yesterday. Yesterday the company had a press release: Ecolab Delivers Very Strong First Quarter Performance; Reported Diluted EPS $1.43; Adjusted Diluted Eps $1.34, +52%; Increased 2024 Adjusted Diluted EPS Outlook: $6.40 - $6.70, +23% - 29%. |
| ACGL | 2.3% | In an impressive move, ARCH CAPITAL GROUP LTD's (NASDAQ:ACGL) shares recorded a 2.3% increase, closing at $93.35 during Tuesday's session. A press release (Arch Capital Group Ltd. Reports 2024 First Quarter Results) was released yesterday. |
| PYPL | 2.28% | With a 2.28% surge, PAYPAL HOLDINGS INC's (NASDAQ:PYPL) stock price reached $68.52 during Tuesday's session, signaling positive momentum. The company's earnings where released Yesterday. |
Our top gainers page will show you the full list.
Losers
| Ticker | Change | Comment |
|---|---|---|
| GEHC | -13.12% | Investors witnessed a 13.12% decrease in GE HEALTHCARE TECHNOLOGY's (NASDAQ:GEHC) stock price, which closed at $77.27 during Tuesday's session. yesterday the company released their earnings. A press release (GE HealthCare Reports First Quarter 2024 Financial Results) was released yesterday. |
| WBD | -9.02% | WARNER BROS DISCOVERY INC's (NASDAQ:WBD) stock price faced a 9.02% decline, reaching $7.42 during Tuesday's session. In the last 3 months the stock lost 20.49%. |
| HUBB | -8.74% | HUBBELL INC's (NYSE:HUBB) stock price is declining with 8.74% to a price of $371.62. HUBBELL INC released earnings Yesterday. Earlier today the company had a press release: Hubbell Reports First Quarter 2024 Results. |
| TAP | -8.46% | There was a downturn in MOLSON COORS BEVERAGE CO - B's (NYSE:TAP) shares, as they experienced a 8.46% decline, closing at $58.18 during Tuesday's session. yesterday the company released their earnings. A press release (Molson Coors Beverage Company Reports 2024 First Quarter Results) was released yesterday. |
| MPC | -7.57% | There was a downturn in MARATHON PETROLEUM CORP's (NYSE:MPC) shares, as they experienced a 7.57% decline, closing at $185.32 during Tuesday's session. MARATHON PETROLEUM CORP released earnings Yesterday. Shareholders saw the stock price going 20.55% higher in the past 3 months. |
| PCAR | -7.35% | PACCAR INC's (NASDAQ:PCAR) stock price faced a 7.35% decline, reaching $105.29 during Tuesday's session. The company's earnings where released Yesterday. Earlier today the company had a press release: PACCAR Achieves Excellent Financial Performance. |
| SBAC | -7.13% | SBA COMMUNICATIONS CORP's (NASDAQ:SBAC) stock price is declining with 7.13% to a price of $187.5. Yesterday the company had a press release: SBA Communications Corporation Reports First Quarter 2024 Results; Updates Full Year 2024 Outlook; and Declares Quarterly Cash Dividend. |
| IT | -7.03% | There was a downturn in GARTNER INC's (NYSE:IT) shares, as they experienced a 7.03% decline, closing at $417.09 during Tuesday's session. GARTNER INC released earnings Yesterday. Yesterday the company had a press release: Gartner Reports First Quarter 2024 Financial Results. |
| FFIV | -6.92% | F5 INC's (NASDAQ:FFIV) shares fell 6.92% to $169.52 during Tuesday's session. A press release (F5 Delivers New Solutions that Radically Simplify Security for Every App and API) was released yesterday. |
| ALGN | -6.31% | There was a notable decline in ALIGN TECHNOLOGY INC's (NASDAQ:ALGN) shares, as they dropped 6.31% to $285.59 during Tuesday's session. In the last 6 months the stock gained 54.39%. |
Our top losers page will show you the full list.
ELI LILLY & CO
NYSE:LLY (5/17/2024, 7:10:55 PM)
After market: 770.75 +0.75 (+0.1%)770
-1.12 (-0.15%)
LLY News
17 hours ago - The Motley FoolIs Amgen a Threat to Eli Lilly in This Billion-Dollar Market?Eli Lilly's biggest growth drivers today are its weight loss drugs.
Eli Lilly's biggest growth drivers today are its weight loss drugs.
2 days ago - QuartzGoogle's big mistake, Walmart's layoffs, OpenAI's new ChatGPT: Business news roundupPlus, an Eli Lilly executive on how to solve the weight loss drug shortage
2 days ago - Zacks Investment ResearchTop Research Reports for Microsoft, Eli Lilly & CostcoToday's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Eli Lilly and Company (LLY) and Costco Wholesale Corporation (COST), as well a micro-cap stock Koss Corporation (KOSS).
2 days ago - InvestorPlacePharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next?Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.
2 days ago - InvestorPlaceRally Rockets: 3 Stocks Benefitting From the Market’s Unstoppable SurgeDon't miss out on profit potential of these stocks to buy. Explore three top stocks poised to unlock gains in a surging market.
2 days ago - Zacks Investment ResearchEli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C ControlEli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
3 days ago - Zacks Investment ResearchEli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowLilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
3 days ago - The Motley FoolMeet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo NordiskCould Amgen be the next stock to soar due to a GLP-1 drug?
3 days ago - BloombergKeeping Muscle While Losing Fat Is Next Goal for Obesity DrugsThe new blockbuster weight-loss shots can help patients trim more pounds than any medicines have before. Now drugmakers are rushing to solve another problem — making sure people keep their muscle even as they shed fat.
3 days ago - CNBCEli Lilly falls on a rival's obesity study — plus, we're removing 3 stocks from our watchlistEvery weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
3 days ago - QuartzEli Lilly says its experimental weekly insulin works just as well as traditional dailiesThe pharma giant known for its diabetes and weight loss medications shared results of it late-stage clinical trail its long-acting insulin efsitora
